Folia Dermatológica Peruana - Vol. 12  Nº. 2 


REFERENCIAS BIBLIOGRÁFICAS


1. Orozco-Covarrubias M, Ruiz-Maldonado R y col. Malignant cutaneous tumors in children: Twenty years of experience at a large pediatric hospital. J Am Acad Dermatol 1994; 30(2): 2434.

2. Seynor G y col. Environmental factors in the etiology of rhabdomyosarcoma in childhood. JNC1 1982; 68(1): 107- 13.

3. Pappo A y col. Up-front window trial of topotecan in previously un treated children and adolescents with  metastatic rhahdomyosarcoma. Lournal of Clinical. Oncology 2001; 19 (1): 213-9.

4. Pediatric Clinics of North America: Primary Subcutaneous Rhabdomyosarcoma 2000; 47 (4).

5. Newton WA, Sould EH y col. Histopatology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. Journal of Clinical Oncology 1988; 6(1): 67-75.

6. Newton WA, Gehan EA y col. Classification of rhabdomyosarcoma and related sarcomas: pathologic     aspects and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study. Cancer 1995; 76(6): 1073-85.

7. Barr E Molecular genetics and pathogenesis of rhabdomyosarcoma. Journal of Pediatric Hematology/Oncology 1997; 19(6): 483-91.

8. Merlino G, Helman LJ Rhabdomyosarcoma - working out the pathways. Oncogene 1999; 18(38): 5340-8.

9. Gordon T, McManus A Y col. Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cylogenetics Group study. Medical and Pediatric Oncology 2001; 36(2): 259-67.

REGRESAR AL ARTÍCULO